Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.
Clinical trial NCT05124925 · COMPLETED
Trial details
- NCT number
- NCT05124925
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-27
- Primary completion
- 2024-06-26
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.